PHARMACOKINETIC AND CLINICAL CONSIDERATIONS IN THE CHOICE OF A HYPNOTIC

被引：17

作者：

AMREIN, R

ECKERT, M

HAEFELI, H

LEISHMAN, B

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 16卷

关键词：

D O I：

10.1111/j.1365-2125.1983.tb02265.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S5 / S10

页数：6

共 11 条

[1]

AMREIN R, 1983, DRUG EXP CLIN RES, V9, P85

[2]

Amrein R, 1980, ZFA (Stuttgart), V56, P1163

[3]

AMREIN R, 1980, BENZODIAZEPINES TODA, P61

[4] PHARMACOKINETICS OF FLUNITRAZEPAM FOLLOWING SINGLE-DOSE AND MULTIPLE-DOSE ORAL-ADMINISTRATION TO HEALTHY HUMAN SUBJECTS [J].

BOXENBAUM, HG ;

POSMANTER, HN ;

MACASIEB, T ;

GEITNER, KA ;

WEINFELD, RE ;

MOORE, JD ;

DARRAGH, A ;

OKELLY, DA ;

WEISSMAN, L ;

KAPLAN, SA .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (04) :283-293

[5]

CANO JP, 1977, ARZNEIMITTEL-FORSCH, V27-2, P2383

[6]

DETTLI L, BENZODIAZEPINES MOL

[7]

GARATTINI S, 1973, BIOL EFFECTS DRUGS R, P211

[8] PHARMACOKINETICS AND BIOAVAILABILITY OF MIDAZOLAM IN MAN [J].

HEIZMANN, P ;

ECKERT, M ;

ZIEGLER, WH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 :S43-S49

[9]

KLOTZ U, 1977, CLIN PHARMACOL THER, V21, P430

[10]

KNOWLES JA, 1972, ARZNEI-FORSCHUNG, V22, P687

← 1 2 →